Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

October 8, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

July 13, 2026July 13, 2026

Why Do We Age? The Biology Of Ageing Explained

1
October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

2
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

3
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

4
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

5
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • Hypsibius exemplaris: a tardigrade as an emerging model for mitochondrial enzyme analysis

THSTI BTech & MSc Life Science Project Associate Recruitment

AIIMS New Delhi Non-Medical Life Science & Microbiology Scientist

Hypsibius exemplaris: a tardigrade as an emerging model for mitochondrial enzyme analysis
  • BiotechToday
  • World

Hypsibius exemplaris: a tardigrade as an emerging model for mitochondrial enzyme analysis

bioxone December 16, 2020December 16, 2020

Ayooshi Mitra, Amity University, Kolkata

Mitochondrial alternative oxidase (AOX) is an enzyme that forms an integral part of the electron transport chain (ETS) in mitochondria. This enzyme is present in the mitochondria of many invertebrates. The expression of AOX in human mitochondria is regarded as a potential therapeutic strategy, regardless of the reason for the occurrence of the enzyme in animal mitochondria. To date, quite some data is available due to heterologous AOX expression in animal cells, but there is no or very little data available on natively expressed AOX. 

The research contributes significantly to the application of animals that express AOX natively. As a model for AOX activity analysis, the study considered the tardigrade, exemplaris. It was observed that in the presence of an AOX inhibitor, the tolerance of Hypsibius exemplaris to blockage of the mitochondrial respiratory chain (MRC) complexes was decreased. It was also noted that the inhibitor-sensitive respiration enabled tardigrade respiration under this blockage condition. In addition, although the detection of AOX at the protein level and the pronounced oxygraphic recording of its activity required the blockage of the MRC complex, the data obtained showed that AOX contributed to animal functioning. The researchers showed that AOX activity in tardigrades can be supervised by measuring the whole-body respiration of the intact specimen. In addition, the impact of MRC complex IV blockage on AOX expression and AOX inhibition in the absence of blockage on the functioning of animals could also be monitored. 

Therefore, Hypsibius exemplaris is prospected to be a useful model organism for the study of the natively expressed mitochondrial alternative oxidase (AOX) enzyme as a whole-animal model. These analyses will help in estimating the impact of the AOX enzyme on animal behavior and the functioning of mitochondria under normal conditions as well as when subjected to external stress factors.

Also read: THE ROLE OF LEWY BODIES IN PARKINSON’S DISEASE

Reference:

  1. Grobys D., Roszkowska M., Kaczmarek Ł., Jarmuszkiewicz W., Karachitos A.,  Kmita H. (2020). The Tardigrade Hypsibius Exemplaris as an Emerging Model to Study the Mitochondrial Alternative Oxidase at Animal Organismal Level. bioRxiv.https://www.biorxiv.org/content/10.1101/2020.12.09.417485v1.full
  • Why Do We Age? The Biology Of Ageing Explained
  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged AOX Enzyme Hypsibius inhibitor invertebrates Mitochondria mitochondrial alternative oxidase MRC complex Tardigrade therapeutics whole-animal model

One thought on “Hypsibius exemplaris: a tardigrade as an emerging model for mitochondrial enzyme analysis”

  1. Pingback: Nuclei of each muscle fiber differ in terms of gene activity - BioXone

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • Job and Internship
  • Signaling Pathway

AIIMS New Delhi Non-Medical Life Science & Microbiology Scientist

bioxone December 16, 2020

-Shristi Sharma, Team bioXone AIIMS Non Medical Scientist Jobs For Life Science/Microbiology. Scientist C (Non Medical) Jobs for PhD Life Science/Microbiology applicants. Interested and eligible applicants can check out all of the details on the same below: Name of the Post: Scientist C (Non Medical) No. of Posts: 01 Name of the Project: “Clinical and […]

Related Post

  • BiotechToday
  • World

Atherosclerosis: Combating the Killer!

bioxone May 6, 2021May 6, 2021

Richismita Hazra, Amity University Kolkata Heart disease is the leading cause of death all across the globe. It can undoubtedly be called as ‘World’s No.1 Killer’. One of the major and common causes of this killer disease is atherosclerosis. Atherosclerosis refers to the piling up of fats, cholesterol, and other substances in and on our […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Depressive disorders and Pharmacotherapy: New info revealed!

BioTech Today July 25, 2021July 24, 2021

Soumya Shraddhya Paul, Amity University, Noida In 2017, depressive disorders were the third biggest cause of non-fatal illness burden worldwide. In the treatment of depressive disorders, pharmacotherapy is an essential component. As of now, the treatment consists of monotherapy using second-generation antidepressants, such as selective serotonin reuptake inhibitors (SSRIs), serotonin and norepinephrine reuptake inhibitors (SNRIs), […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Genome editing by CRISPR-CAS9 to treat ATRT

bioxone December 14, 2020December 14, 2020

Devyani Goswami, Amity University Kolkata CRISPR-CAS9 a huge discovery in the biomedical field which guarantees curing various genetic disorders has been used and a topic of research among various scientists. Due to this the scientists discovering CRISPR-CAS9 were awarded the Nobel Prize of Chemistry, 2020. Utilizing this concept a group of scientists tried to treat […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

Why Do We Age? The Biology Of Ageing Explained

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy